iwCAR-T 2026: advances in TIL therapy for solid tumors
Welcome to another episode of VJOncology Podcast, featuring a roundtable discussion from iwCAR-T 2026, which took place in Tampa, FL. This week, our experts explore advances in tumor-infiltrating lymphocyte (TIL) therapy for solid tumors. Join Benjamin Creelan from Moffitt Cancer Center, Rodabe Amaria from the University of Texas MD Anderson Cancer Center, Daniel Olson from the University of Chicago, and Lilit Karapetyan from Moffitt Cancer Center as they discuss sequencing, duration issues and armoring approaches for TIL therapy in melanoma and other solid tumors.
Suggested videos
Immunotherapy updates in head and neck cancer from ASCO 2026
VJOncology · 18:35
Improving TIL therapy for solid tumors: engineering, persistence, and implementation
VJOncology · 19:08
Phase I trial of ICV-delivered bivalent CAR T-cells in glioblastoma
VJOncology · 2:46
What is the future role of ctDNA as a biomarker in colorectal cancer?
VJOncology · 2:07
Updates in surgical oncology at ESSO 45
VJOncology · 19:21
Safety and efficacy outcomes of SMART-based SABR in ultracentral NSCLC
VJOncology · 1:23
Reprogramming the tumor microenvironment: targeting acidity to unlock antitumor immunity
VJOncology · 11:53
The future of assessing brain tumors with CSF-based liquid biopsies
VJOncology · 2:14